Treatment outcomes of venetoclax-combination regimens for relapsed/refractory myeloid malignancies after anti-CD47-directed therapy.

Rafael Madero-MarroquinEmily DworkinHoward WeinerCaner SayginMariam T NawasMichael W DrazerAdam S DuVallSatyajit KosuriMichael J ThirmanOlatoyosi OdenikeWendy StockRichard A LarsonAnand Ashwin Patel

Published in: Leukemia & lymphoma (2024)

Keyphrases

acute myeloid leukemia
acute lymphoblastic leukemia
diffuse large b cell lymphoma
multiple myeloma
dendritic cells
bone marrow
hodgkin lymphoma
stem cells
nk cells
immune response
cell therapy
replacement therapy